Existing Account

Please login first to complete purchase/ quotation request, view custom order reports, or create favorites list.

Customer ID:
Stay Logged In

Forgot your Customer ID or Password?
New Account

Don't have an account with us yet? Please set up an account to place order or obtain customer services.

Assay Kits  >  Secretase Assay Kits  >>  SensoLyte ® 520 TACE (α-Secretase) Activity Assay Kit *Fluorimetric*

Product Name SensoLyte ® 520 TACE (α - Secretase) Activity Assay Kit *Fluorimetric*
Size 1 kit
Catalog # AS-72085
US$ $457

TACE (tumor necrosis factor-alpha converting enzyme), α-secretase, or ADAM17 is a member of the ADAM family of proteases that contain both disintegrin and metalloprotease (catalytic) domains. This enzyme is involved in sperm-egg binding and fusion, muscle cell fusion, neurogenesis, modulation of Notch receptor and ligand processing, and processing of the pro-inflammatory cytokine, TNFα. TACE is currently being explored as a target for anti-inflammatory drugs.

SensoLyte® 520 TACE Activity Assay Kit uses a 5-FAM (fluorophore) and QXL® 520 (quencher) labeled FRET peptide substrate for continuous measurement of enzyme activity. In the intact FRET peptide, the fluorescence of 5-FAM is quenched by QXL® 520. Upon cleavage of the FRET peptide by the active enzyme, the fluorescence of 5-FAM is recovered, and can be continuously monitored at excitation/emission = 490 nm/520 nm. With superior fluorescence quantum yield and longer emission wavelength, 5-FAM/QXL® 520 based FRET peptide has less interference from the autofluorescence of test compounds and cellular components and provides better assay sensitivity. The kit can be used to detect the activity of TACE or screen for TACE inhibitors. The assays are performed in a convenient 96-well format.

Kit size: 100 assays

Detailed Information Datasheet
Material Safety Data Sheets (MSDS)
Storage -20°C
Product Citations Lorenzen, I. et al. (2016). Control of ADAM17 activity by regulation of its cellular localisation. Sci Rep 6, 35067. doi: 10.1038/srep35067

Jedicke, N. et al. (2014). Alpha-1-antitrypsin inhibits acute liver failure in mice. Hepatology 59, 2299. doi: 10.1002/hep.27024.

Omote, K. et al. (2014). Role of the TNF pathway in the progression of diabetic nephropathy in KK-Ay mice. Am J Physiol Renal doi: 10.1152/ajprenal.00509.2013.

Xu, X. et al. (2014). MUC1 in Macrophage: Contributions to Cigarette Smoke–Induced Lung Cancer. Cancer Res 74, 460. doi: 10.1158/0008-5472.CAN-13-1713.

Fiorentino, L. et al. (2013). Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. EMBO Mol Med 5, 441. doi: 10.1002/emmm.201201475.

Foster, RR. et al. (2013). Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro. Am J Pathol 183, 604. doi: 10.1016/j.ajpath.2013.04.019.

Fukaya, S. et al. (2013). Overexpression of TNF-α-converting enzyme in fibroblasts augments dermal fibrosis after inflammation. Lab Invest 93, 72. doi: 10.1038/labinvest.2012.153.

Kawasaki, S. et al. (2013). Regulation of TNFα converting enzyme activity in visceral adipose tissue of obese mice. Biochem Biophys Res Commun 430, 1189. doi: 10.1016/j.bbrc.2012.12.086.

Kitamura, T. et al. (2013). Bile acid accelerates erbB2-induced pro-tumorigenic activities in biliary tract cancer. Mol Carcinogenesis doi: 10.1002/mc.22118.

Lee, J-H. et al. (2013). HIV Nef, Paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases. Mol Cell 49, 668. doi: 10.1016/j.molcel.2012.12.004.

Liu, W. et al. (2013). Arg972 Insulin receptor substrate-1 is associatedwith decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidence. Cardiovasc Diabetol 12, 151. doi: 10.1186/1475-2840-12-151.

Lockett, AD. et al. (2013). α1-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α. Am J Resp Cell Mol 49, 143. doi: 10.1165/rcmb.2012-0515OC.

Menghini, R. et al. (2013). Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus. Acta Diabetol. doi: 10.1007/s00592-013-0478-6.

Rao, S. et al. (2013). Spleen tyrosine kinase (Syk)-dependent calcium signals mediate efficient CpG-induced exocytosis of tumor necrosis factor α (TNFα) in innate immune cells. J Biol Chem 288, 12448. doi: 10.1074/jbc.M113.454405.

Tripathy, D. et al. (2013). Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study. Diabetologia 56, 2153. doi: 10.1007/s00125-013-2976-z.

Wang, Y. et al. (2013). Strain-induced differentiation of fetal type II epithelial cells is mediated via the Integrin α6β1-ADAM17/Tumor Necrosis Factor-α-converting Enzyme (TACE) Signaling Pathway. J Biol Chem 288, 25646. doi: 10.1074/jbc.M113.473777.

Akool, ES. et al. (2012). Cyclosporin A and tacrolimus induce renal Erk1/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling. Biochem Pharmacol 83, 286. doi: 10.1016/j.bcp.2011.11.001.

Catalán, U. et al. (2012). Inhibition of the transcription factor c-Jun by the MAPK family, and not the NF-kB pathway, suggests that peanut extract has anti-inflammatory properties. Mol Immunol 52, 125. doi: 10.1016/j.molimm.2012.05.007.

Chanthaphavong, RS. et al. (2012). A Role for cGMP in inducible nitric-oxide synthase (iNOS)-induced Tumor Necrosis Factor (TNF) α-converting Enzyme (TACE/ADAM17) activation, translocation, and TNF Receptor 1 (TNFR1) shedding in hepatocytes. J Biol Chem 287, 35887. doi: 10.1074/jbc.M112.365171.

Costa, GN. et al. (2012). Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose. Mol Cell Neurosci 50, 113. doi: 10.1016/j.mcn.2012.04.003.

Jijon, HB. et al. (2012). The EGF receptor and HER2 participate in TNF-α-dependent MAPK activation and IL-8 secretion in intestinal epithelial cells. Mediat Inflamm 2012, 12 pages. doi: 10.1155/2012/207398

Marolda, R. et al. (2012). Substance P activates ADAM9 mRNA expression and induces α-secretase-mediated amyloid precursor protein cleavage. Neuropharmacol 62, 1954. doi: 10.1016/j.neuropharm.2011.

Schmidt, V. et al. (2012). Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer’s disease. EMBO 31,187. doi: 10.1038/emboj.2011.352.

Cardellini, M. et al. (2011). Decreased IRS2 and TIMP3 expression in monocytes from offspring of Type 2 diabetic patients is correlated with insulin resistance and increased Intima-Media thickness. Diabetes 60, 3265. doi: 10.2337/db11-0162.

Guma, M. et al. (2011). Constitutive intestinal NF-kB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med 208, 1889. doi: 10.1084/jem.20110242.

Oguma, T. et al. (2011). Induction of Mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells. J Immunol 187, 999. doi: 10.4049/jimmunol.1002257.

Roher, N. et al. (2011). Endotoxin recognition in fish results in inflammatory cytokine secretion not gene expression. Innate Immunity 17, 16. doi: 10.1177/1753425909348232.

Stöhr, O. et al. (2011). Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease. Age 35, 83. doi: 10.1007/s11357-011-9333-2.

Takasugi, N. et al. (2011). BACE1 activity is modulated by cell-associated Sphingosine-1-Phosphate. J Neurosci 31, 6850. doi: 10.1523/JNEUROSCI.6467-10.2011.

Yang, Y. et al. (2011). Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice. J Neuroinflam 8, 108. doi: 10.1186/1742-2094-8-108.

Zhao, XQ. et al. (2011). CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme. J Lipid Res doi: 10.1194/jlr.M015156.

Hassemer, EL. et al. (2010). The waved with open eyelids (woe) locus is a hypomorphic mouse mutation in Adam17. Genetics 185, 245. doi: 10.1534/genetics.109.113167.

Cardellini, M. et al. (2009). TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58, 2396. doi: 10.2337/db09-0280.

Fiorentino, L. et al. (2009). Increased tumor necrosis factor α-converting enzyme activity induces insulin resistance and hepatosteatosis in mice. Hepatol 51, 103. doi: 10.1002/hep.23250.

Hurst, LA. et al. (2009). Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. J Neuroimmunol 210, 108. doi: 10.1016/j.jneuroim.2009.02.008.

Walker, EJ. et al. (2009). TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Exp Neuro 216, 122.
  < Back